Marvin Walker Sexton, MD | |
1450 Ross Clark Cir Ste 400, Dothan, AL 36301-4770 | |
(334) 305-0400 | |
(334) 305-0401 |
Full Name | Marvin Walker Sexton |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 28 Years |
Location | 1450 Ross Clark Cir Ste 400, Dothan, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659365138 | NPI | - | NPPES |
051553599 | Medicaid | AL | |
267234100 | Medicaid | FL | |
650015945A | Medicaid | GA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 21089 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Southeast Alabama Medical Center | Dothan, AL | Hospital |
Flowers Hospital | Dothan, AL | Hospital |
Medical Center Enterprise | Enterprise, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pulmonary Associates, Pa | 8022031475 | 11 |
Houston County Healthcare Authority | 9436062296 | 196 |
News Archive
A new analysis has found that breast cancer survivors may experience problems with certain mental abilities several years after treatment, regardless of whether they were treated with chemotherapy plus radiation or radiation only.
The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded $1 million to each of three Boston-area biotech companies through its 2010 Biotech Investment Awards program: Constellation Pharmaceuticals, Inc., Epizyme, Inc. and Karyopharm Therapeutics, Inc. Since the inception of this MMRF program in 2006, $11 million has been committed to 11 biotech companies in multi-year, results-driven funding for the development of innovative treatments for patients with multiple myeloma.
As e-cigarettes become more popular, fewer people are taking up smoking traditional cigarettes. But can e-cigarettes, an electronic nicotine delivery system, help people quit smoking altogether? That was the focus of a recent study led by a Hollings Cancer Center researcher.
Researchers at Monash University have found physical differences in the brains of people who respond emotionally to others' feelings, compared to those who respond more rationally, in a study published in the journal NeuroImage.
› Verified 2 days ago
Entity Name | Houston County Healthcare Authority |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619026606 PECOS PAC ID: 9436062296 Enrollment ID: O20040219000209 |
News Archive
A new analysis has found that breast cancer survivors may experience problems with certain mental abilities several years after treatment, regardless of whether they were treated with chemotherapy plus radiation or radiation only.
The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded $1 million to each of three Boston-area biotech companies through its 2010 Biotech Investment Awards program: Constellation Pharmaceuticals, Inc., Epizyme, Inc. and Karyopharm Therapeutics, Inc. Since the inception of this MMRF program in 2006, $11 million has been committed to 11 biotech companies in multi-year, results-driven funding for the development of innovative treatments for patients with multiple myeloma.
As e-cigarettes become more popular, fewer people are taking up smoking traditional cigarettes. But can e-cigarettes, an electronic nicotine delivery system, help people quit smoking altogether? That was the focus of a recent study led by a Hollings Cancer Center researcher.
Researchers at Monash University have found physical differences in the brains of people who respond emotionally to others' feelings, compared to those who respond more rationally, in a study published in the journal NeuroImage.
› Verified 2 days ago
Entity Name | Pulmonary Associates, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912987785 PECOS PAC ID: 8022031475 Enrollment ID: O20060111000817 |
News Archive
A new analysis has found that breast cancer survivors may experience problems with certain mental abilities several years after treatment, regardless of whether they were treated with chemotherapy plus radiation or radiation only.
The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded $1 million to each of three Boston-area biotech companies through its 2010 Biotech Investment Awards program: Constellation Pharmaceuticals, Inc., Epizyme, Inc. and Karyopharm Therapeutics, Inc. Since the inception of this MMRF program in 2006, $11 million has been committed to 11 biotech companies in multi-year, results-driven funding for the development of innovative treatments for patients with multiple myeloma.
As e-cigarettes become more popular, fewer people are taking up smoking traditional cigarettes. But can e-cigarettes, an electronic nicotine delivery system, help people quit smoking altogether? That was the focus of a recent study led by a Hollings Cancer Center researcher.
Researchers at Monash University have found physical differences in the brains of people who respond emotionally to others' feelings, compared to those who respond more rationally, in a study published in the journal NeuroImage.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Marvin Walker Sexton, MD Po Box 2266, Dothan, AL 36302-2266 Ph: (334) 305-0400 | Marvin Walker Sexton, MD 1450 Ross Clark Cir Ste 400, Dothan, AL 36301-4770 Ph: (334) 305-0400 |
News Archive
A new analysis has found that breast cancer survivors may experience problems with certain mental abilities several years after treatment, regardless of whether they were treated with chemotherapy plus radiation or radiation only.
The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded $1 million to each of three Boston-area biotech companies through its 2010 Biotech Investment Awards program: Constellation Pharmaceuticals, Inc., Epizyme, Inc. and Karyopharm Therapeutics, Inc. Since the inception of this MMRF program in 2006, $11 million has been committed to 11 biotech companies in multi-year, results-driven funding for the development of innovative treatments for patients with multiple myeloma.
As e-cigarettes become more popular, fewer people are taking up smoking traditional cigarettes. But can e-cigarettes, an electronic nicotine delivery system, help people quit smoking altogether? That was the focus of a recent study led by a Hollings Cancer Center researcher.
Researchers at Monash University have found physical differences in the brains of people who respond emotionally to others' feelings, compared to those who respond more rationally, in a study published in the journal NeuroImage.
› Verified 2 days ago
Parks Winfield Pratt Iii, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4300 W Main St, Suite 102, Dothan, AL 36305 Phone: 334-793-9564 Fax: 334-671-8907 | |
Mr. Rodney K Beauchamp, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 200 Parkwest Cir Ste 2, Dothan, AL 36303 Phone: 334-699-2004 | |
Brian Reynolds Sinclair, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1450 Ross Clark Cir Ste 400, Dothan, AL 36301 Phone: 334-305-0400 Fax: 334-305-0401 | |
Dr. Olawale Mayokun Osunsanya, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1763 E Main St, Dothan, AL 36301 Phone: 334-793-3319 Fax: 334-793-2291 | |
Jeffrey John Crittenden, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 480 Honeysuckle Rd, Dothan, AL 36305 Phone: 334-836-1212 Fax: 334-836-1888 | |
Dr. Venkat R Nimmagadda, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1540 E Main St, Dothan, AL 36301 Phone: 334-793-2618 Fax: 334-792-7353 | |
Christopher O. Ike, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4300 W Main St Ste 102, Dothan, AL 36305 Phone: 334-793-9564 Fax: 334-340-2805 |